Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13
Original Research
Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,102 | Dovepress* | 4,404+ | 330 | 4,734 | |
| PubMed Central* | 698 | 199 | 897 | ||
| Totals | 5,102 | 529 | 5,631 | ||
| *Since 10 September 2021 | |||||
View citations on PubMed Central and Google Scholar